
Jennifer E. Graser
Examiner (ID: 2460)
| Most Active Art Unit | 1645 |
| Art Unit(s) | 1802, 1645, 1641, 1621 |
| Total Applications | 1924 |
| Issued Applications | 1280 |
| Pending Applications | 238 |
| Abandoned Applications | 464 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16400134
[patent_doc_number] => 20200340992
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-29
[patent_title] => DNA APTAMER SPECIFICALLY BINDING TO ESAT6, AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/649747
[patent_app_country] => US
[patent_app_date] => 2018-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4761
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16649747
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/649747 | DNA aptamer specifically binding to ESAT6, and use thereof | Sep 18, 2018 | Issued |
Array
(
[id] => 16541309
[patent_doc_number] => 20200407722
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-31
[patent_title] => DNA APTAMER SPECIFICALLY BINDING TO TB7.7, AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/649856
[patent_app_country] => US
[patent_app_date] => 2018-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4744
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16649856
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/649856 | DNA aptamer specifically binding to TB7.7, and use thereof | Sep 18, 2018 | Issued |
Array
(
[id] => 16282691
[patent_doc_number] => 20200276293
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-03
[patent_title] => BACTERIAL PROTEIN COMPOSITIONS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/647692
[patent_app_country] => US
[patent_app_date] => 2018-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24919
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16647692
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/647692 | Bacterial protein compositions and uses thereof | Sep 18, 2018 | Issued |
Array
(
[id] => 18909293
[patent_doc_number] => 11872256
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-01-16
[patent_title] => Bacteriophage composition and method of preventing bacterial infections in livestock
[patent_app_type] => utility
[patent_app_number] => 16/647445
[patent_app_country] => US
[patent_app_date] => 2018-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 11
[patent_no_of_words] => 9664
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16647445
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/647445 | Bacteriophage composition and method of preventing bacterial infections in livestock | Sep 13, 2018 | Issued |
Array
(
[id] => 13795763
[patent_doc_number] => 20190011420
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-10
[patent_title] => POTENCY TEST FOR VACCINE FORMULATIONS
[patent_app_type] => utility
[patent_app_number] => 16/129144
[patent_app_country] => US
[patent_app_date] => 2018-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5434
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16129144
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/129144 | POTENCY TEST FOR VACCINE FORMULATIONS | Sep 11, 2018 | Abandoned |
Array
(
[id] => 16977618
[patent_doc_number] => 20210221855
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-22
[patent_title] => RECOMBINANT VACCINE AGAINST PROLIFERATIVE ENTEROPATHY IN ANIMALS
[patent_app_type] => utility
[patent_app_number] => 16/643147
[patent_app_country] => US
[patent_app_date] => 2018-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6726
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16643147
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/643147 | Recombinant vaccine against proliferative enteropathy in animals | Aug 27, 2018 | Issued |
Array
(
[id] => 13604017
[patent_doc_number] => 20180353557
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-13
[patent_title] => LACTIC ACID BACTERIUM, DRUG, FOOD OR DRINK, AND FEED WHICH CONTAIN THE LACTIC ACID BACTERIUM
[patent_app_type] => utility
[patent_app_number] => 16/105467
[patent_app_country] => US
[patent_app_date] => 2018-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6108
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16105467
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/105467 | Lactic acid bacterium, drug, food or drink, and feed which contain the lactic acid bacterium | Aug 19, 2018 | Issued |
Array
(
[id] => 15524765
[patent_doc_number] => 20200054688
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-20
[patent_title] => Method for Precise Identification, Targeting and Delivery of Directed Therapies to Domesticated Animals Using Bacteria to Bind and Destroy Cancerous Cells
[patent_app_type] => utility
[patent_app_number] => 16/104168
[patent_app_country] => US
[patent_app_date] => 2018-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27924
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16104168
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/104168 | Method for Precise Identification, Targeting and Delivery of Directed Therapies to Domesticated Animals Using Bacteria to Bind and Destroy Cancerous Cells | Aug 16, 2018 | Abandoned |
Array
(
[id] => 17741442
[patent_doc_number] => 11389487
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-07-19
[patent_title] => None
[patent_app_type] => utility
[patent_app_number] => 16/637068
[patent_app_country] => US
[patent_app_date] => 2018-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 9
[patent_no_of_words] => 13040
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16637068
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/637068 | None | Aug 5, 2018 | Issued |
Array
(
[id] => 13574969
[patent_doc_number] => 20180339033
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-29
[patent_title] => Methods for the Prevention of Salmonella Infections
[patent_app_type] => utility
[patent_app_number] => 16/052843
[patent_app_country] => US
[patent_app_date] => 2018-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12607
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -36
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16052843
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/052843 | Methods for the prevention of | Aug 1, 2018 | Issued |
Array
(
[id] => 15993969
[patent_doc_number] => 20200172855
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-04
[patent_title] => GENETICALLY MODIFIED HAPLOID ISSATCHENKIA ORIENTALIS
[patent_app_type] => utility
[patent_app_number] => 16/638251
[patent_app_country] => US
[patent_app_date] => 2018-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7971
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16638251
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/638251 | Genetically modified haploid | Aug 1, 2018 | Issued |
Array
(
[id] => 13604081
[patent_doc_number] => 20180353589
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-13
[patent_title] => Vaccines and Compositions for the Prevention of Salmonella Infections
[patent_app_type] => utility
[patent_app_number] => 16/051933
[patent_app_country] => US
[patent_app_date] => 2018-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12603
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16051933
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/051933 | Vaccines and compositions for the prevention of | Jul 31, 2018 | Issued |
Array
(
[id] => 13604083
[patent_doc_number] => 20180353590
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-13
[patent_title] => Manufacture of Vaccines and Compositions for the Prevention of Salmonella Infections
[patent_app_type] => utility
[patent_app_number] => 16/051961
[patent_app_country] => US
[patent_app_date] => 2018-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12590
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16051961
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/051961 | Manufacture of vaccines and compositions for the prevention of | Jul 31, 2018 | Issued |
Array
(
[id] => 16718662
[patent_doc_number] => 20210085809
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-25
[patent_title] => ENHANCEMENT OF PATHOGEN IMMUNOGENICITY
[patent_app_type] => utility
[patent_app_number] => 16/634221
[patent_app_country] => US
[patent_app_date] => 2018-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11707
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16634221
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/634221 | ENHANCEMENT OF PATHOGEN IMMUNOGENICITY | Jul 26, 2018 | Abandoned |
Array
(
[id] => 14040821
[patent_doc_number] => 20190076517
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-14
[patent_title] => PRODUCTION OF RECOMBINANT VACCINE IN E.COLI BY ENZYMATIC CONJUGATION
[patent_app_type] => utility
[patent_app_number] => 16/034906
[patent_app_country] => US
[patent_app_date] => 2018-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13482
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16034906
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/034906 | Production of recombinant vaccine in | Jul 12, 2018 | Issued |
Array
(
[id] => 14040821
[patent_doc_number] => 20190076517
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-14
[patent_title] => PRODUCTION OF RECOMBINANT VACCINE IN E.COLI BY ENZYMATIC CONJUGATION
[patent_app_type] => utility
[patent_app_number] => 16/034906
[patent_app_country] => US
[patent_app_date] => 2018-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13482
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16034906
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/034906 | Production of recombinant vaccine in | Jul 12, 2018 | Issued |
Array
(
[id] => 16013569
[patent_doc_number] => 20200181627
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-11
[patent_title] => PROMOTER FOR HETEROLOGOUS EXPRESSION
[patent_app_type] => utility
[patent_app_number] => 16/631999
[patent_app_country] => US
[patent_app_date] => 2018-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22727
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16631999
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/631999 | Promoter for heterologous expression | Jul 10, 2018 | Issued |
Array
(
[id] => 13733281
[patent_doc_number] => 20180371108
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-27
[patent_title] => Antibody specific to staphylococcus aureus, therapeutic method and detection method using same
[patent_app_type] => utility
[patent_app_number] => 16/027538
[patent_app_country] => US
[patent_app_date] => 2018-07-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11511
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16027538
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/027538 | Antibody specific to | Jul 4, 2018 | Issued |
Array
(
[id] => 15396175
[patent_doc_number] => 10538733
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-01-21
[patent_title] => Compositions and methods for treatment of bacterial infections
[patent_app_type] => utility
[patent_app_number] => 16/023004
[patent_app_country] => US
[patent_app_date] => 2018-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 49
[patent_no_of_words] => 15270
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16023004
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/023004 | Compositions and methods for treatment of bacterial infections | Jun 28, 2018 | Issued |
Array
(
[id] => 16266530
[patent_doc_number] => 20200268017
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-27
[patent_title] => PROBIOTIC COMPOSITIONS AND METHODS
[patent_app_type] => utility
[patent_app_number] => 16/630675
[patent_app_country] => US
[patent_app_date] => 2018-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6922
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16630675
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/630675 | PROBIOTIC COMPOSITIONS AND METHODS | Jun 19, 2018 | Abandoned |